Latest Listings And Ipos News

Klevo Rewards Limited has been granted a crucial two-week extension by the ASX to meet reinstatement conditions and avoid automatic removal from the official list. The new deadline is now 1 December 2025.

RPMGlobal shareholders are set to vote on Caterpillar’s $5.00 per share acquisition proposal following Federal Court approval to convene a Scheme Meeting. The Independent Expert deems the offer fair and reasonable, with the RPM Board unanimously backing the deal.

Antaria has disclosed several FDA-identified GMP compliance issues but assures no impact on product quality or supply, committing to expert-led remediation and enhanced training.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.

Diablo Resources has appointed Matthew Blumberg as a Non-Executive Director and brought on Ellis Martin as its U.S. Media and Investor Communications Advisor, signaling a strategic push into North American markets.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.

Capricorn Metals Ltd has had its CMMO securities class suspended from ASX trading pending regulatory compliance, raising questions about the company’s next steps.

Catalyst Metals has resolved a key legal dispute to gain 100% ownership of the Plutonic Gold Belt, clearing the way to boost gold production and extend mine life in Western Australia.

Radiopharm Theranostics has reached the halfway mark in enrolling patients for its Phase 2b trial of RAD101, a novel imaging agent targeting brain metastases. Early data suggest RAD101 may outperform MRI in distinguishing tumor recurrence from radiation damage.

Right Resources has completed early works and secured permits to launch a 4,800m diamond drilling program at its high-grade Pilot Project in Tumbarumba, NSW, following a successful $10 million IPO.

Red Mountain Mining has secured approval to list on the US OTCQB market, with trading set to begin on November 17, 2025. The move enhances liquidity and positions the company to leverage US government funding for its critical minerals projects.